/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Intensity Therapeutics Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$0.3999 0.1505(15.05%) INTS at 04 Dec 2025 04:35 PM Biotechnology
Lowest Today 0.3599
Highest Today 0.4149
Today’s Open 0.35995
Prev. Close 0.3562
52 Week High 3.17
52 Week Low 0.19
Day’s Range: Low 0.3599 High 0.4149
52-Week Range: Low 0.19 High 3.17
1 day return -
1 Week return +2.23
1 month return -24.02
3 month return +47.42
6 month return -9.93
1 year return -84.35
3 year return -
5 year return -
10 year return -

Institutional Holdings

Sentinus, LLC 0.42

Brown Advisory Holdings Inc 0.28

Mesirow Fin Investmt Mgmt Intl Equity 0.23

Geode Capital Management, LLC 0.15

Sigma Planning Corp 0.15

Warberg Asset Management LLC 0.15

Jane Street Group LLC 0.10

Fidelity Extended Market Index 0.09

Vanguard Group Inc 0.09

Blair William & Co 0.08

One Charles Private Wealth Services, LLC 0.07

Vanguard Institutional Extnd Mkt Idx Tr 0.06

HRT FINANCIAL LLC 0.05

XTX Topco Ltd 0.05

QTR Family Wealth, LLC 0.04

Stonebridge Financial Group, LLC 0.04

EWA, LLC 0.03

BOOTHBAY FUND MANAGEMENT, LLC 0.03

State Street Corp 0.03

Northern Trust Corp 0.03

Virtu Financial LLC 0.03

Tower Research Capital LLC 0.03

Fidelity Series Total Market Index 0.02

Fidelity Total Market Index 0.02

Northern Trust Extended Eq Market Idx 0.02

NT Ext Equity Mkt Idx Fd - L 0.02

Fidelity Nasdaq Composite Index 0.01

NT Ext Equity Mkt Idx Fd - NL 0.01

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.01

Spartan Total Market Index Pool G 0.01

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

NT Ext Eq Mkt Indx Fd DC Lend T3 0.00

Northern Trust Wilshire 5000 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

Market Status

Strong Buy: 1

Buy: 2

Hold: 2

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 21.40 M

PB Ratio 3.1621

PE Ratio 0.0

Enterprise Value 15.89 M

Total Assets 4.78 M

Volume 2029324

Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-8877099 -8.9M, FY22:-7451058 -7.5M, FY21:-7892991 -7.9M, FY20:-5956471 -6.0M, FY19:-5229129 -5.2M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-7000 -0.0M, Q1/2025:-6000 -0.0M, Q3/2024:null 0.0M, Q2/2024:-6000 -0.0M

Quarterly Net worth Q3/2025:-2671000 -2.7M, Q2/2025:-2537000 -2.5M, Q1/2025:-3347000 -3.3M, Q3/2024:-3513000 -3.5M, Q2/2024:-4971000 -5.0M

Fund house & investment objective

Company Information Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Organisation Biotechnology

Employees 5

Industry Biotechnology

CEO Mr. Lewis H. Bender M.A., M.B.A., M.S.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow